<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04884113</url>
  </required_header>
  <id_info>
    <org_study_id>W20.204</org_study_id>
    <nct_id>NCT04884113</nct_id>
  </id_info>
  <brief_title>PowerSpiral Enteroscopy Performance and Safety</brief_title>
  <official_title>PowerSpiral Enteroscopy: Multicenter Prospective Study on Performance and Safety Including Patients With Altered Gastrointestinal Anatomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Antonius Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Antonius Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicenter study to evaluate the efficacy of the motorized spiral enteroscope in the&#xD;
      management of small bowel diseases.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and Aims:&#xD;
&#xD;
      Motorized Spiral enteroscopy is a recent advancement in enteroscopy. Data are scarce on the&#xD;
      utility and safety of the motorized spiral enteroscopy. No data is available on the utility&#xD;
      of this technique in patients with altered gastrointestinal (GI) anatomy.&#xD;
&#xD;
      This study aimed to evaluate the efficacy of motorized spiral enteroscopy including rate of&#xD;
      total enteroscopy (TER) in patients undergoing enteroscopy for suspected small bowel disease&#xD;
      including those with altered GI anatomy.&#xD;
&#xD;
      Methods: A multicenter prospective study evaluated consecutive patients with symptomatic&#xD;
      small bowel disease who underwent enteroscopy over a 12-month period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The diagnostic yield of motorized spiral enteroscopy</measure>
    <time_frame>2 days</time_frame>
    <description>Diagnostic yield achieved by antegrade and/or retrograde enteroscopy using motorized spiral enteroscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The therapeutic yield of motorized spiral enteroscopy</measure>
    <time_frame>2 days</time_frame>
    <description>Total number of therapeutic interventions performed during antegrade and/or retrograde enteroscopy using the motorized spiral enteroscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total enteroscopy rate</measure>
    <time_frame>2 days</time_frame>
    <description>Estimate the number of total enteroscopy procedures achieved by either antegrade only or antegrade and retrograde motorized spiral enteroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>2 days</time_frame>
    <description>Estimate the rate of technically successful enteroscopy procedures both antegrade and retrograde motorized spiral enteroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total procedural time</measure>
    <time_frame>2 days</time_frame>
    <description>The total time needed to complete the whole procedure of enteroscopy antegrade and/or retrograde motorized spiral enteroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depth of maximum insertion into the small bowel</measure>
    <time_frame>2 days</time_frame>
    <description>Estimation of the maximum depth of insertion (in centimeters) both antegrade and/or retrograde motorized spiral enteroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>7 days</time_frame>
    <description>Total minor and also serious adverse events during and after antegrade and/or retrograde motorized spiral enteroscopy</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Small Bowel Disease</condition>
  <arm_group>
    <arm_group_label>Experimental: Motorized Spiral Enteroscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procedure: Motorized Spiral Enteroscopy:&#xD;
PowerSpiral enteroscope will be inserted and advanced with the assistance of motorized spiral rotation, After reaching the point of maximum insertion, cecum or if no further advancement of the enteroscope can be achieved, the enteroscope will be withdrawn using motorized counter-clockwise spiral rotation. When no total enteroscopy is reached, submucosal ink dye injection is performed as an endoscopically visible marker of the maximum insertion depth. A retrograde enteroscopy is then performed in the same session or at second session</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Motorized Spiral enteroscopy</intervention_name>
    <description>Small-bowel enteroscopy for diagnosis and intervention</description>
    <arm_group_label>Experimental: Motorized Spiral Enteroscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18 years and older&#xD;
&#xD;
          2. Patients with suspected small bowel pathology indicated for diagnostic and/or&#xD;
             therapeutic enteroscopy based on clinical presentation, small bowel imaging, or video&#xD;
             capsule enteroscopy&#xD;
&#xD;
          3. Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Contraindications for endoscopy because of comorbidities&#xD;
&#xD;
          2. Unable to provide written informed consent&#xD;
&#xD;
          3. Patients with known severe gastrointestinal tract inflammation, intestinal&#xD;
             obstruction, gastroesophageal varices or eosinophilic esophagitis that preclude a safe&#xD;
             enteroscopy procedure&#xD;
&#xD;
          4. Coagulopathy or thrombocytopenia that could not be corrected by blood product&#xD;
             transfusion&#xD;
&#xD;
          5. Pregnant patients&#xD;
&#xD;
          6. Health status: American Society of Anesthesiologists (ASA) class &gt;3&#xD;
&#xD;
          7. Inability to tolerate Propofol sedation or general anesthesia for any reason&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A Al-Toma, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Antonius Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>A Al-Toma, Ph.D.</last_name>
    <phone>+3883205660</phone>
    <email>a.altoma@antoniusziekenhuis.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>VU University Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>6813KJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H Beaumont, PHD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Centre Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700 RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JJ MC Koornstra, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Centre</name>
      <address>
        <city>Leiden</city>
        <zip>2311ZN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J vd Kraan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maastricht UMC+</name>
      <address>
        <city>Maastricht</city>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R de Ridder</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Antonius hospital</name>
      <address>
        <city>Utrecht</city>
        <zip>3430 EM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A Al-Toma</last_name>
      <phone>+31883205660</phone>
      <email>a.altoma@antoniusziekenhuis.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2021</study_first_posted>
  <last_update_submitted>May 13, 2021</last_update_submitted>
  <last_update_submitted_qc>May 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Antonius Hospital</investigator_affiliation>
    <investigator_full_name>Abdulbaqi Al-Toma</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Motorized Spiral enteroscopy</keyword>
  <keyword>Device-assisted enteroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

